|
|
Nanovibronix Inc (NASDAQ: NAOV) |
|
Price: $0.4121
$0.01 
3.283%
|
| Day's High:
| $0.4239
| Week Perf:
| -17.58 %
|
| Day's Low: |
$ 0.38 |
30 Day Perf: |
-28.95 % |
| Volume (M): |
396 |
52 Wk High: |
$ 1.52 |
| Volume (M$): |
$ 163 |
52 Wk Avg: |
$0.72 |
| Open: |
$0.40 |
52 Wk Low: |
$0.37 |
|
|
| Market Capitalization (Millions $) |
1 |
| Shares
Outstanding (Millions) |
3 |
| Employees |
64 |
| Revenues (TTM) (Millions $) |
3 |
| Net Income (TTM) (Millions $) |
-3 |
| Cash Flow (TTM) (Millions $) |
2 |
| Capital Exp. (TTM) (Millions $) |
0 |
Nanovibronix Inc
Company Address: 969 Pruitt Ave Tyler 77569 TX
Company Phone Number: 233-3004 Stock Exchange / Ticker: NASDAQ NAOV
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Business Update
Published Mon, Jan 6 2025 2:07 PM UTC
NanoVibronix, Inc. (NASDAQ: NAOV) has recently announced a significant milestone in their ongoing efforts to revolutionize medical device technology, particularly in the realm of ultrasonic therapeutic applications. This past week marked the successful completion of the pilot phase of a Randomized Control Trial (RCT) study of their innovative UroShield device, conducted by r...
|
| Business Update
Published Wed, Dec 11 2024 2:47 PM UTC
NanoVibronix Secures $12 Million Commitment, Extends PainShield Distribution Agreement with Ultra Pain Products In a significant move poised to enhance its market footprint, NanoVibronix, Inc. (NASDAQ: NAOV), a leading medical device company renowned for its innovative therapeutic solutions, announced a pivotal development in its commercial strategy. The company has secured ...
|
| Business Update
Published Tue, Nov 12 2024 3:36 PM UTC
In recent months, NanoVibronix, Inc. (NASDAQ: NAOV) has seized the spotlight in the medical device industry, showcasing significant strides in commercialization and distribution. With innovative products like UroShield, PainShield, and WoundShield, the company is embedding itself in the therapeutic landscape. CEO Brian Murphy?s recent communications to stockholders highlig...
|
| Business Update
Published Wed, Aug 21 2024 2:47 PM UTC
ELMSFORD, N.Y. In a recent letter addressed to shareholders, Brian Murphy, CEO of NanoVibronix, Inc. (NASDAQ: NAOV), shed light on the company s impressive performance during the second quarter. As a pioneering medical device firm, NanoVibronix specializes in the development of innovative therapeutic devices, namely UroShield, PainShield, and WoundShield, which utilize cu...
|
| Business Update
Published Thu, May 16 2024 1:15 PM UTC
TYLER, Texas -- NanoVibronix, Inc. (NASDAQ: NAOV), a pioneering medical device company known for its Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, namely UroShield, PainShield, and WoundShield, has recently issued a comprehensive letter to its stockholders. This communication, delivered by Chief Executive Officer Brian Murphy, provides a detailed revi...
|
| Per Share |
Current |
| Earnings (TTM) |
-1.26 $ |
| Revenues (TTM) |
0.92 $
|
| Cash Flow (TTM) |
0.56 $ |
| Cash |
0.47 $
|
| Book Value |
0.67 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-1.26 $
|
| Revenues (TTM) |
0.92 $ |
| Cash Flow (TTM) |
0.56 $ |
| Cash |
0.47 $
|
| Book Value |
0.67 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
| UNITED STATES |
|
 92.82 % |
of total Revenue |
| Europe |
|
2.13 % |
of total Revenue |
| Australia New Zealand |
|
1.86 % |
of total Revenue |
| Other |
|
3.19 % |
of total Revenue |
|
|
0.8%